Sodium valproate inhibits production of TNF-α and IL-6 and activation of NF-κB

Brain Research

Volumn 857, Issue 1-2, 2000, Pages 246-251

  Ichiyama, Takashi ^a   Okada, Kuniyuki ^b   Lipton, James M ^b   Matsubara, Tomoyo ^a   Hayashi, Takashi ^a   Furukawa, Susumu ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Interleukin 6; NF B; TNF ; Valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIAZEPAM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PHENOBARBITAL; PHENYTOIN; TUMOR NECROSIS FACTOR ALPHA; VALPROIC ACID;

ARTICLE; CELL LINE; CELL SPECIFICITY; CONTROLLED STUDY; ELECTROPHORESIS; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTICONVULSANTS; CELLS, CULTURED; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA; VALPROIC ACID;

EID: 0033955359     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02439-7     Document Type: Article

References (40)

1. Andersen P., Moseklide L. Immunoglobulin levels and autoantibodies in epileptics on long-term anticonvulsant therapy. Acta Med. Scand. 201:1977;69-74.
2. Auphan N., DiDonato J.A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids: inhibition of IκB synthesis. Science. 270:1995;286-290.
3. Baeuerle P.A., Henkel T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
4. Baldwin A.S. Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:1996;649-683.
5. Basaran N., Kansu E., Hical F. Serum immunoglobulins, complement levels and lymphocyte subpopulations in phenytoin-treated epileptic patients. Immunopharmacol. Immunotoxicol. 11:1989;335-346.
6. Brown K., Gerstberger S., Carlson L., Franzoso G., Siebenlist U. Control of IκBα proteolysis by site-specific, signal-induced phosphorylation. Science. 267:1995;1485-1488.
7. Clarke C.J.P., Taylor-Fishwick D.A., Hales A., Chernajovsky Y., Sugamura K., Feldmann M., Foxwell B.M.J. Interleukin-4 inhibits κ light chain expression and NFκB activation but not IκBα degradation in 70Z/3 murine pre-B cells. Eur. J. Immunol. 25:1995;2961-2966.
8. Collart M.A., Baeuerle P., Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol. Cell. Biol. 10:1990;1498-1506.
9. Delude R.L., Fenton M.J., Savedra R. Jr., Perera P.Y., Vogel S.N., Thieringer R., Golenbock D.T. CD14-mediated translocation of nuclear factor-κB induced by lipopolysaccharide does not require tyrosine kinase activity. J. Biol. Chem. 269:1994;22253-22260.
10. Eustice D.C., Feldman P.A., Colberg-Poly A.M., Buckery R.M., Neubauer R.H. A sensitive method for the detection of β-galactosidase in transfected mammalian cells. Biotechniques. 11:1991;739-742.
11. Fujiwara K., Yoshida A., Ochi M., Yoshioka H., Sawada T., Kusunoki T., Kasubuchi Y. Serum immunoglobulin levels in children receiving valproic acid. Brain Dev. 5:1983;199.
12. Garson P., Gonzalez-Cornejo S., Roman-Maldonado S., Navarro-Ruiz A. Valproic acid and phenytoin effects on serum proteins and immunoglobulins of epileptic patients. Gen. Pharmacol. 16:1985;411-413.
13. Grimm S., Baeuerle P.A. The inducible transcription factor NF-κB: structure-function relationship of its protein subunits. Biochem. J. 290:1993;297-308.
14. Henkel T., Machleidt T., Alkalay I., Krönke M., Ben-Neriah Y., Baeuerle P.A. Rapid proteolysis of IκBα is necessary for activation of transcriptional factor NF-κB. Nature. 365:1993;182-185.
15. Hiscott J., Marois J., Garoufalis J., D'Addario M., Roulston A., Kwan I., Pepin N., Lacoste J., Nguyen H., Bensi G., Fenton M. Characterization of a functional NF-κB site in the human interleukin-1β promoter: evidence for a positive autoregulatory loop. Mol. Cell. Biol. 13:1993;6231-6240.
16. Ichiyama T., Sakai T., Catania A., Barsh G.S., Furukawa S., Lipton J.M. Systemically administered α-melanocyte-stimulating peptides inhibit NF-κB activation in experimental brain inflammation. Brain Res. 836:1999;31-37.
17. Ichiyama T., Zhao H., Catania A., Furukawa S., Lipton J.M. α-Melanocyte-stimulating hormone inhibits NF-κB activation and IκBα degradation in human glioma cells and in experimental brain inflammation. Exp. Neurol. 157:1999;359-365.
18. Joubert P.H., Aucamp A.K., Potgieter G.M., Verster F. Epilepsy and IgA deficiency - the effect of sodium valproate. S. Afr. Med. J. 52:1977;642-644.
19. Kumar A., Haque J., Lacoste J., Hiscott J., Williams B.R.G. Double-stranded RNA-dependent protein kinase activates transcription factor NF-κB by phosphorylating IκB. Proc. Natl. Acad. Sci. U.S.A. 91:1994;6288-6292.
20. Kunsch C., Lang R.K., Rosen C.A., Shannon M.F. Synergistic transcriptional activation of the IL-8 gene by NF-κB p65 (RelA) and NF-IL-6. J. Immunol. 153:1994;153-164.
21. Lenti C., Masserini C., Peruzzi C., Guareschi Cazullo A. Effects of carbamazepine and valproate on immunological assessment in young epileptic patients. Ital. J. Neurol. Sci. 12:1991;87-91.
22. Lentsch A.B., Shanley T.P., Sarma V., Ward P.A. In vivo suppression of NF-κB and preservation of IκBα by interleukin-10 and interleukin-13. J. Clin. Invest. 100:1997;2443-2448.
23. Libermann T.A., Baltimore D. Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol. Cell. Biol. 10:1990;2327-2334.
24. Liu S.F., Ye X., Malik A.B. Pyrrolidine dithiocarbamate prevents IκB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs. Mol. Pharmacol. 55:1999;658-667.
25. Mahon T.M., O'Neill L.A.J. Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-κB activation in T-lymphocytes. J. Biol. Chem. 270:1995;28557-28564.
26. Manna S.K., Aggarwal B.B. IL-13 suppresses TNF-induced activation of nuclear factor-κB, activation protein-1, and apoptosis. J. Immunol. 161:1998;2863-2872.
27. Manna S.K., Aggarwal B.B. α-Melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-κB activation induced by various inflammatory agents. J. Immunol. 161:1998;2873-2880.
28. Marienfeld R., Neumann M., Chuvpilo S., Escher C., Kneitz B., Avots A., Schimpl A., Serfling E. Cyclosporin A interferes with the inducible degradation of NF-κB inhibitor, but not with the processing of p105/NF-κB1 in T cells. Eur. J. Immunol. 27:1997;1601-1609.
29. Masi M., Paolucci P., Perocco P., Franceschi C. Immunosuppression by phenytoin. Lancet. 1:1976;860.
30. Matsusaka T., Fujikawa K., Nishio Y., Mukaida N., Matsushima K., Kishimoto T., Akira S. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin-6 and interleukin-8. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10193-10197.
31. Natarajan K., Singh S., Burke T.R. Jr., Grunberger D., Aggarwal B.B. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB. Proc. Natl. Acad. Sci. U.S.A. 93:1996;9090-9095.
32. Pacifici R., Paris L., Di Carlo S., Bacosi A., Pichini S., Zuccaro P. Cytokine production in blood mononuclear cells from epileptic patients. Epilepsia. 36:1995;384-387.
33. Queiroz M.L., Mullen P.W. Effects of sodium valproate on the immune response. Int. J. Immunopharmacol. 14:1992;1133-1137.
34. Roy S., Cain K.J., Chapin R.B., Charboneau R.G., Barke R.A. Morphine modulates NFκB activation in macrophages. Biochem. Biophys. Res. Commun. 245:1998;392-396.
35. Scheinman R.I., Cogswell P.C., Lofquist A.K., Baldwin A.S. Jr. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science. 270:1995;283-286.
36. Schreiber A.A., Frei K., Lichtensteiger W., Schlumpf M. The effect of prenatal diazepam exposure on TNF-α production by rat splenocytes. Agents Actions. 38:1993;265-272.
37. Seeler J.S., Muchardt C., Podar M., Gaynor R.B. Regulatory elements involved in Tax-mediated transactivation of the HTLV-1 LTR. Virology. 196:1993;442-450.
38. Sen R., Baltimore D. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell. 47:1986;921-928.
39. Sun W.H., Keller E.T., Stebler B.S., Ershler W.B. Estrogen inhibits phorbol ester-induced IκBα transcription and protein degradation. Biochem. Biophys. Res. Commun. 244:1998;691-695.
40. Yin M., Yamamoto Y., Gaynor R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β Nature. 396:1998;77-80.